Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Chicago, Illinois 25 trials found
New Search
Filter
Trial Phase
Study Type
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
N/AOBSERVATIONAL Chicago, Illinois
RECRUITING
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Stanford, California +4 more
RECRUITING
Blue Light Cystoscopy With Cysview® Registry
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
NAINTERVENTIONAL La Jolla, California +2 more
RECRUITING
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
PHASE2, PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine
PHASE1INTERVENTIONAL Chicago, Illinois +3 more
RECRUITING
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Pan Tumor Rollover Study
PHASE2INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
N/AOBSERVATIONAL Chicago, Illinois +4 more
RECRUITING
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients
PHASE2INTERVENTIONAL Chicago, Illinois +4 more
RECRUITING
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
PHASE2INTERVENTIONAL San Francisco, California +4 more
RECRUITING
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
N/AOBSERVATIONAL Millville, Delaware +4 more
RECRUITING
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
PHASE2INTERVENTIONAL West Los Angeles, California +4 more
RECRUITING
Lidocaine Infusion in Pancreatic Cancer
EARLY_PHASE1INTERVENTIONAL Chicago, Illinois
RECRUITING
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
PHASE1, PHASE2INTERVENTIONAL Tampa, Florida +4 more
RECRUITING
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
PHASE2INTERVENTIONAL Chicago, Illinois
RECRUITING
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type